Maxillary Sinusitis Clinical Trial
Official title:
Single-step Functional Sinus Endoscopy and Transoral Surgery Enhance Odontogenic Sinusitis Treatment Outcomes: a Randomized Controlled Trial
Dento- alveolar or dental structural diseases that affect the floor of the maxillary sinus can cause maxillary sinusitis which is known as odontogenic maxillary sinusitis (OMS). Many treatment protocols have been documented to treat OMS. However, There is no unanimity among clinicians on how and who should treat OMS, whether is it otolaryngologist, oral/maxillofacial surgeons, or dentist. Therefore, this study will be will be enrolled to evaluate the efficacy of the Single-step Functional Sinus endoscopy and trans-oral surgery in the management of maxillary sinusitis raised from Odontogenic origin via Department- integrated therapy.
The OMS is a well-known but understudied kind of sinusitis that necessitates a treatment regimen different from non-odontogenic sinusitis. It requires specialized attention because it differs in its pathophysiology, microbiology, diagnosis, and therapy than other forms of non-odontogenic sinusitis. There are several surgical techniques have been published to treat odontogenic maxillary sinusitis, such as transoral, transnasal endoscopic, or combined techniques. Multiple specialists are daily facing patients with maxillary sinusitis either odontogenic or non-odontogenic, including otolaryngologist, maxillofacial/oral, and dental surgeons. The direct transoral method, which involves making a bone window in the anterolateral maxillary wall, is more familiar to maxillofacial/oral surgeons, whereas the transnasal endoscopic approach is gaining favor, particularly among otolaryngologists. There is no unanimity among clinicians on how and who should treat OMS, whether it is otolaryngologist, maxillofacial, or oral surgeon. This is one of the reasons why the results are frequently challenged as reported by others. Therefore, this study will be will be enrolled to evaluate the efficacy of the Single-step Functional Sinus endoscopy and trans-oral surgery in the management of maxillary sinusitis raised from Odontogenic origin via Department- integrated therapy. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04903418 -
Assessment of Relationship Between Maxillary Sinus Floor and Maxillary Posterior Teeth Root Tips Position
|
||
Completed |
NCT00683371 -
Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis
|
N/A | |
Completed |
NCT00236652 -
A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.
|
Phase 3 | |
Recruiting |
NCT04241016 -
Endoscopic Sinus Surgery in Recurrent Acute Rhinosinusitis
|
N/A | |
Not yet recruiting |
NCT03083392 -
Endosseous Oroantral Port for Minimal Intervention in Treating Chronic Sinusitis
|
N/A | |
Completed |
NCT00668304 -
Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox
|
Phase 4 | |
Recruiting |
NCT04645511 -
Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.
|
N/A | |
Not yet recruiting |
NCT02931604 -
Study Designed to Clinically Evaluate Sinus Wash Device Prototypes
|
N/A | |
Completed |
NCT00643409 -
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults
|
Phase 3 | |
Terminated |
NCT00245440 -
Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis
|
Phase 4 | |
Completed |
NCT00537563 -
AMS VS MOXI Ketek vs Avelox in AMS
|
Phase 3 | |
Completed |
NCT00249210 -
A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses
|
Phase 3 | |
Completed |
NCT01032174 -
Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis
|
N/A |